STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug

RegulatoryEnbrelPositive

AI Analysis

Summary

A federal judge blocked Colorado's attempt to implement a price cap on Amgen's Enbrel drug. The ruling prevents the state panel from placing restrictions on pricing for the blockbuster medication.

Outcome Details

Federal judge blocked Colorado state panel from placing price cap on Enbrel

Importance:6/10

Sentiment:

0.70

pricinglitigationregulatoryprice controlsColorado

Related Companies

$AMGN

Read the original article

Published by STAT News on July 2, 2026 12:54 PM

Read Original